Carcinoid Heart Disease Management: A Multi-Disciplinary Collaboration.
Quick Facts
What This Study Found
25%-65% of patients with carcinoid syndrome develop carcinoid heart disease.
Key Numbers
How They Did This
The article reviews existing guidelines and emphasizes the need for early screening and multidisciplinary collaboration in managing CaHD.
Why This Research Matters
Improving adherence to management guidelines can enhance patient outcomes and reduce morbidity and mortality associated with CaHD.
What This Study Doesn't Tell Us
The study primarily focuses on existing guidelines without new experimental data or direct patient outcomes.
Trust & Context
- Original Title:
- Carcinoid Heart Disease Management: A Multi-Disciplinary Collaboration.
- Published In:
- The oncologist, 28(7), 575-583 (2023)
- Authors:
- Das, Satya, Stockton, Shannon S, Hassan, Saamir A
- Database ID:
- RPEP-06824
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-06824APA
Das, Satya; Stockton, Shannon S; Hassan, Saamir A. (2023). Carcinoid Heart Disease Management: A Multi-Disciplinary Collaboration.. The oncologist, 28(7), 575-583. https://doi.org/10.1093/oncolo/oyad126
MLA
Das, Satya, et al. "Carcinoid Heart Disease Management: A Multi-Disciplinary Collaboration.." The oncologist, 2023. https://doi.org/10.1093/oncolo/oyad126
RethinkPeptides
RethinkPeptides Research Database. "Carcinoid Heart Disease Management: A Multi-Disciplinary Col..." RPEP-06824. Retrieved from https://rethinkpeptides.com/research/das-2023-carcinoid-heart-disease-management
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.